Eurazeo-owned healthcare VC investor Kurma Partners has closed its fourth Biofund on €215m, a 34% jump compared to its predecessor vehicle in the strategy. Despite that capital increase, BioFund IV came in below the €250m fundraising aim Kurma revealed in October 2024, at the time of the vehicle's €140m first close. Never miss a story! […]
The post Eurazeo's Kurma Partners raises €215m for fourth Biofund appeared first on AltAssets Private Equity News.
|
